The Elevai E-Series product range, a pre-and post-procedure skincare system developed with a proprietary stem cell exosome technology, will now be available to dermatologists and plastic surgeons throughout Canada.  

Evolve Medical Inc. is the exclusive distributor for Elevai Skincare products in Canada.

The Elevai E-Series product range, a pre-and post-procedure skincare system developed with a proprietary stem cell exosome technology, will now be available to dermatologists and plastic surgeons throughout Canada.  

 “After 35 years in cosmetic dermatology and skincare, I’ve been fortunate to launch products like JUVÉDERM and BOTOX Cosmetic2 in Canada as well as bringing best-in-class medical skincare products including ZO Skin Health and skinbetter science to Canada. I’ve been waiting for a series of products that will not only take us to a new level in anti-aging but will also change the way we think about aging. Elevai is about to change our world, ” says Sharon Clarke, CEO of EVOLVE Medical Inc. in a news release.

“We are excited about this exclusive distribution agreement as part of our ongoing international distribution strategy,” shares Chris Kraneiss, Chief Commercial Officer for Elevai Labs. “We have no doubt that Evolve Medical will be a productive partner and will help grow the Elevai footprint in Canada enabling more physicians and patients to benefit from this innovative, next- generation skincare line.”

Elevai will also be exhibiting at Aesthetic and Anti-Aging Medicine World Congress taking place February 23-25 in Miami. In addition to exhibiting at the conference, Elevai cofounder Jordan R. Plews, PhD and dermatologist Natalie Curcio, MD, will be speaking at two educational sessions related to exosomes and regenerative aesthetics.